PISCAZZI, ANNAMARIA
 Distribuzione geografica
Continente #
NA - Nord America 1.048
EU - Europa 902
AS - Asia 335
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
OC - Oceania 1
Totale 2.291
Nazione #
US - Stati Uniti d'America 1.042
IE - Irlanda 316
CN - Cina 258
UA - Ucraina 183
SE - Svezia 157
IT - Italia 76
DE - Germania 66
SG - Singapore 47
FR - Francia 35
FI - Finlandia 28
TR - Turchia 19
BE - Belgio 14
CZ - Repubblica Ceca 8
GB - Regno Unito 8
NL - Olanda 7
IN - India 5
MX - Messico 3
CA - Canada 2
EU - Europa 2
JP - Giappone 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BR - Brasile 1
CL - Cile 1
CR - Costa Rica 1
EE - Estonia 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
PL - Polonia 1
RO - Romania 1
VN - Vietnam 1
Totale 2.291
Città #
Dublin 316
Chandler 205
Jacksonville 130
New York 118
Nyköping 116
Dearborn 85
Nanjing 64
Ashburn 45
Munich 44
Ann Arbor 35
Beijing 32
Princeton 32
Singapore 30
Nanchang 26
Wilmington 24
San Mateo 19
Foggia 18
Los Angeles 16
Brussels 14
Hebei 14
Helsinki 12
Shenyang 12
Des Moines 11
Kunming 11
Tianjin 11
Changsha 9
Brno 8
Jinan 8
Boardman 7
Jiaxing 7
Hangzhou 6
Bari 5
Chieti 5
Guangzhou 5
Lanzhou 5
Ningbo 5
Washington 5
Woodbridge 5
Zhengzhou 5
Changchun 4
London 4
Norwalk 4
Taizhou 4
Potenza 3
Redwood City 3
San Severo 3
Bitonto 2
Chicago 2
Ferrandina 2
Istanbul 2
Milan 2
Rome 2
San Jose 2
Seattle 2
Stevenage 2
Toronto 2
Amityville 1
Amman 1
Amsterdam 1
Ardabil 1
Augusta 1
Belo Horizonte 1
Berlin 1
Borås 1
Boston 1
Bucharest 1
Chengdu 1
Chestnut Hill 1
Clearwater 1
Dongguan 1
Dung 1
Forlimpopoli 1
Fuyang 1
Fuzhou 1
Hanover 1
Hilden 1
Illange 1
Kashiwa 1
Kraków 1
Las Vegas 1
Lavagna 1
Lekkerkerk 1
Mexico 1
Nocera Terinese 1
Nürnberg 1
Orange 1
Osio Sotto 1
Paola 1
Paris 1
Perth 1
Portland 1
Pune 1
Qingdao 1
Rovereto 1
Rozzano 1
San José 1
Santa Clara 1
Shanghai 1
Shijiazhuang 1
Taiyuan 1
Totale 1.614
Nome #
TRAP1 regulates cell cycle and apoptosis in thyroid carcinoma cells 104
DAAs rapidly reduce inflammation but increase serum VEGF level: A rationale for tumor risk during anti-HCV treatment 104
DAAs increase serum VEGF level: a rationale for tumour risk recurrence during anti-HCV treatment 96
Erlotinib enhances the proapoptotic activity of cytotoxic agents and synergizes with paclitaxel in poorly-differentiated thyroid carcinoma cells. 95
TRAP1 favor glycolytic metabolism and resistance to EGFR inhibitors in human colorectal carcinoma through regulation of PFK. 93
Activation of the RAS/RAF/ERK signaling pathway contributes to resistance to sunitinib in thyroid carcinoma cell lines 84
COMPARATIVE GENE EXPRESSION PROFILING OF TOBACCO-ASSOCIATED HPV-POSITIVE VERSUS NEGATIVE ORAL SQUAMOUS CARCINOMA CELL LINES. 82
RAS/BRAF mutational status in familial non-medullary thyroid carcinomas: A retrospective study 81
NOTCH SIGNALLING MODULATES HYPOXIA-INDUCED NEUROENDOCRINE DIFFERENTIATION OF HUMAN PROSTATE CANCER CELLS 80
Sorcin induces a drug-resistant phenotype in human colorectal cancer through the modulation of Ca2+ homeostasis. 78
Analysis of the mutational status of the BRAF oncogene in familiar non-medullary thyroid carcinomas. 78
TRAP1 controls cell cycle progression through the regulation of CDK1 and MAD2 expression/ubiquitination in human breast, colon and lung carcinomas. 78
Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinoma 77
Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1 76
TRAP1 controls cell cycle G2–M transition through the regulation of CDK1 and MAD2 expression/ubiquitination 76
TRAP1 favors glycolytic metabolism and resistance to EGFR inhibitors in human colorectal carcinoma through regulation of PFK. 72
TRAP1 is a novel molecular target in BRAF-driven human colorectal carcinomas 70
The reciprocal regulation between TRAP1 and BRAF is responsible for control of cell cycle progression and modulation of mitochondrial apoptotic pathway. 70
TRAP1 and sorcin cooperate in a survival pathway responsible for inducing drug-resistance in human colorectal carcinoma. 68
Cyclin-dependent kinase 1 targeting improves sensitivity to radiation in BRAF V600E colorectal carcinoma cells 68
Epidermal growth factor receptor 1 expression is upregulated in undifferentiated thyroid carcinomas in humans. 68
ER stress protection by TRAP1 induces resistance to paclitaxel in breast carcinoma cells 66
TRAP1 enhances Warburg metabolism through modulation of PFK1 expression/activity and favors resistance to EGFR inhibitors in human colorectal carcinomas. 64
The Role of Survivin in Thyroid Tumors: Differences of Expression in Well-Differentiated, Non–Well-Differentiated, and Anaplastic Thyroid Cancers 63
TRAP1 enhances Warburg metabolism through modulation of PFK1 expression/activity and favors resistance to EGFR inhibitors in human colorectal carcinomas 61
KRAS and BRAF mutational status predicts the sensitivity of thyroid carcinoma cell lines to sunitinib. 59
TRAP1 induces a multi-drug resistant phenotype in BRAF V600E colorectal carcinoma cells by reducing the activation of mitochondrial ERK and favoring resistance to apoptosis. 56
Obstructive Sleep Apnea Worsens Progression-Free and Overall Survival in Human Metastatic Colorectal Carcinoma 51
Comparative gene expression profiling of tobacco-associated HPV-positive versus negative oral squamous carcinoma cell lines 48
IDH1 Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment-Current State and Future Perspectives 46
IDH1 Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment-Current State and Future Perspectives 45
Differential and divergent activity of insulin-like growth factor binding protein 6 in platinum-sensitive versus platinum-resistant high-grade serous ovarian carcinoma cell lines 43
Evidence‐based second‐line treatment in ras wild‐type/mutated metastatic colorectal cancer in the precision medicine era 34
TRAP1 regulates the response of colorectal cancer cells to hypoxia and inhibits ribosome biogenesis under conditions of oxygen deprivation 30
Pancreatic Enzyme Replacement and Nutritional Support With nab-Paclitaxel-based First-Line Chemotherapy Regimens in Metastatic Pancreatic Cancer 28
TRAP1 modulates mitochondrial biogenesis via PGC-1α/TFAM signalling pathway in colorectal cancer cells 4
Totale 2.396
Categoria #
all - tutte 12.975
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.975


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020263 0 0 0 0 52 57 54 10 39 5 36 10
2020/2021217 31 0 26 8 29 7 31 17 32 33 0 3
2021/2022187 22 4 4 2 23 3 8 15 16 20 5 65
2022/2023870 70 44 53 31 53 86 2 74 402 6 16 33
2023/2024278 37 8 11 10 12 137 5 13 0 9 0 36
2024/2025116 23 42 12 23 16 0 0 0 0 0 0 0
Totale 2.396